Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

HOUSTON — White House and State Department officials have told U.S. oil executives in recent weeks that they would need to return to Venezuela quickly and invest significant capital in the country to ...

Disease control and symptom remission at weeks 12 and 24 were greatest among patients with chronic spontaneous urticaria receiving omalizumab 300 mg compared with dupilumab and remibrutinib.